Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jun 17, 2022 10:18am
125 Views
Post# 34764176

RE:Increasing commitment from the top!

RE:Increasing commitment from the top!
GoldenInvestor wrote:

Our exec chairman clearly inst going anywhere and as an experienced capital allocator, is showing the world that we clearly have a GUD thing going on here with all the money he keeps in Knight.

his creation, the SS GUD, is one ship he's continuing to be on board with!  


when you see a founder, CEO and intelligent investor continue to accumulate after he's passed the CEO duties to his top lieutenant, one can see he has continued and increasing confidence.

GUD times ahead!

GI



And he's likely going to spend a lot more time schmoozing the finance boys in general.

Don't forget a recent advisory board appointement at Maverix where he joined the likes of Ruffolo and team (May 2021).

"... Jonathan Goodman, co-founder, President and CEO of publicly traded Paladin Labs Inc., which was acquired in 2014 by Endo International In. (NASDAQ: ENDP) for $3.2 billion will be joining the Maverix Advisory board as its 6th member. The Maverix Advisory Board represents a who's who of successful Canadian entrepreneurs and business leaders, who share a similar mission, to help build the next wave of disruptive Canadian businesses."



<< Previous
Bullboard Posts
Next >>